Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    8598866 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
Condition: Coronary Artery Disease
Intervention: Drug: unfractionated heparin
2 Active, not recruiting Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation
Conditions: Coronary Artery Disease;   Atrial Fibrillation
Interventions: Drug: 6 weeks;   Drug: 6 months

Indicates status has not been verified in more than two years